Recent work (Krafft et al., Cell 2013) has demonstrated that amyloid beta oligomers are the synaptotoxic entity at the earliest stages of Alzheimer’s Disease. Acelot has identified novel brain-penetrant small molecule antagonists of synaptotoxic amyloid oligomer action. Acelot has identified several families of potential oligomer antagonists via the JPS…
Read MoreIt is widely held that soluble Aβ oligomers are the most neurotoxic form of Aβ and that a compromised Aβ clearance rate in the brain may be one cause for late-onset Alzheimer’s disease. Key proteins that mediate Aβ clearance, are ApoE and the ABCA1 lipid transporter. Recent studies from…
Read More